Chinese Delegation Heads to Israel to Explore Cannabis
(Ctech) — A delegation of Chinese entrepreneurs and academic researchers in the fields of technology and agriculture will meet cannabis researchers in Israel next week. The delegation is also set to meet with Israeli firms working in the field, including pharmaceutical companies and those developing technological innovations in the medicinal use of the plant.
Israel is considered a world leader in medical marijuana research, which the government and academic world have both actively participated in for decades. Raphael Mechoulam, a professor of medicinal chemistry at the Hebrew University of Jerusalem, was the first person to identify the main psychoactive constituent in cannabis, THC.
The country’s relatively advanced regulatory framework for medical marijuana trials facilitates research: more than 70 startups developing cannabis-related technology and products currently operate in Israel, with most established in recent years.
Last week, Tel Aviv-based cannabis inhaler company Syqe Medical Ltd. raised $50 million in a funding round.
The Israeli government is expected to soon approve new reforms that would for the first time permit the nation to export medical marijuana.
The Chinese delegation intends to seek scientific collaborations, said Ascher Shmulewitz, chairman of Israeli cannabis company Therapix Biosciences Ltd., on Sunday. Shmulewitz will accompany the researchers during their visit.
In October, Therapix entered into an acquisition agreement with Canadian company FSD Pharma Inc., but the acquisition hit a snag in December and its future is uncertain.
According to a November report by New Frontier Data, a Washington-based market research and analytics firm specializing in the cannabis industry, China controls over a third of the global hemp market — though the U.S. may soon provide serious competition, after a farm bill U.S. President Donald Trump signed in December legalized industrial hemp growth there. Hemp has a variety of uses today, from textiles and construction materials to biofuel, health foods and healthcare-related products.
This story was originally published in C-Tech.
- 1After Junk Downgrade, China’s Largest Developer Announces $441 Million Bond Buyback
- 2Less Than 0.1% of Shanghai’s Hospitalized Covid Patients Develop Severe Illness, Study Shows
- 3CATL Unveils Battery That Power a Car Up to 1,000 Kilometers on One Charge
- 4China Junk Bond Selloff Enters New Phase With Record Fosun Rout
- 5China Resumes More International Flights as Crippling Covid Curbs Ease
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas